GlassScriptPhysician profile
Adam Buck
NPI 1053004341
$1,679.79
in general payments reported to CMS, 2019-2025
15 companies · $50.26 in 2025
The $50.26 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $491 · 2024: $1,139 · 2025: $50.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,372 · Travel and Lodging: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,372.26 |
| Travel and Lodging | $307.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $565.22 | 2023-2024 | Venclose Maven Catheter |
| Amgen INC. | $248.91 | 2023-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $142.06 | 2023-2024 | Camzyos |
| Limflow INC. | $134.62 | 2023 | Limflow System |
| Alnylam Pharmaceuticals INC. | $133.67 | 2024 | Amvuttra |
| Recor Medical INC | $112.04 | 2024 | Paradise Renal Denervation System |
| Lexicon Pharmaceuticals, INC. | $78.06 | 2023-2024 | Inpefa |
| Silk Road Medical, INC. | $50.29 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cvrx, INC. | $50.26 | 2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $41.71 | 2023 | Verquvo |
| Pfizer INC. | $34.67 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.03 | 2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $22.81 | 2024 | Xarelto |
| Novo Nordisk INC | $16.51 | 2023 | Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $14.93 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Buck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.